We are live on
!
Find out more
FNCH
Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH
Delisted
FNCH was delisted on the 24th of May, 2024.
Fund managers haven’t disclosed any holdings of FNCH yet.
FNCH Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Finch Therapeutics Group, Inc. Common Stock (FNCH) for Q3 2024, worth a combined $0 — down 100% from $29.1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of FNCH and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Lake Street Advisors Group, exiting entirely with an estimated $29.1K sold.
- 0 institutional investors held Finch Therapeutics Group, Inc. Common Stock (FNCH) as of Q3 2024, down from 1 in Q2 2024.
- Funds reported $0 of Finch Therapeutics Group, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Finch Therapeutics Group, Inc. Common Stock positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Finch Therapeutics Group, Inc. Common Stock seller in Q3 2024 was Lake Street Advisors Group, an estimated $29.1K sold.
Based on aggregated 13F filings for Q3 2024.